Microsomal prostaglandin E synthase-1 inhibition prevents adverse cardiac remodeling after myocardial infarction in mice.
Yuze ZhangJulia Steinmetz-SpähHelena IdborgLiyuan ZhuHuihui LiHaojie RaoZengrong ChenZiyi GuoLejia HuChuansheng XuHong ChenMarina KorotkovaPer-Johan JakobssonMiao WangPublished in: British journal of pharmacology (2023)
metabolite ratio and therefore represents a potential therapeutic strategy for development of HFrEF post-MI.